Contact Lens Spectrum

References

July 2020

Document #296

(p. 12) Prescribing for Presbyopia – See Through the Fog
By Brooke Messer, OD

  1. Rueff EM, Varghese RJ, Brack TM, Downard DE, Bailey MD. A Survey of Presbyopic Contact Lens Wearers in a University Setting. Optom Vis Sci. 2016 Aug;93:848-854.

(p. 15) GP Insights – Aren’t My Eyes Too Dry to Wear Contact Lenses?
By Karen DeLoss, OD

  1. Pritchard N, Fonn D, Brazeau D. Discontinuation of contact lens wear: a survey. Int Contact Lens Clin.1999 Nov;26:157-162.
  2. Goyal S, Hamrah P. Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches. Semin Ophthalmol. 2016;31(1-2):59-70.

(p. 16) Dry Eye Dx and Tx – Curcumin: A Potential Therapy for Dry Eye?
By William Townsend, OD

  1. Hessen M, and Akpek EK. Dry Eye: An Inflammatory Ocular Disease. J Ophthalmic Vis Res. 2014 Apr;9:240-250.
  2. Abidi A, Shukla P, Ahmad A. Lifitegrast: A novel drug for treatment of dry eye disease. J Pharmacol Pharmacother. 2016 Oct-Dec;7:194-198.
  3. Radomska-Leśniewska DM, Osiecka-Iwan A, HycA. Therapeutic potential of curcumin in eye diseases. Cent Eur J Immunol. 2019;44(2):181-189.
  4. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007 Apr;5:75-92.
  5. Hewlings SJ Douglas S. Kalman DS. Curcumin: A Review of Its’ Effects on Human Health. Foods. 2017 Oct 22;6:92.
  6. Liu X, Hao J, Xie T, et al. Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review. Front Pharmacol. 2017 Feb 14;8:66.
  7. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007 Jul;60:171-177.
  8. Fong PY, Shih KC, Lam PY, Chan TCY, Jhanji V, Tong L. Role of tear film biomarkers in the diagnosis and management of dry eye disease. Taiwan J Ophthalmol. 2019 Sep 12;9:150-159.
  9. Kimura K. Molecular mechanism of the disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha, a proinflammatory cytokine. Nippon Ganka Gakkai Zasshi. 2010 Nov;114:935-943.
  10. Chen M, Hu DN, Pan Z, Lu CW, Xue C-Y, Aass I. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res. 2010 Mar;90:437-443.

(p. 17) Contact Lens Care & Compliance – Cosmetics and Contact Lens Wer
By Melissa Barnett, OD

  1. Hidden in Makeup. Women’s Statistics. Available at http://hiddeninmakeup.weebly.com/statistics.html . Accessed May 22, 2020.
  2. Statista Research Department. 2019 Aug 20. Available at https://www.statista.com/statistics/276377/us-households-usage-of-mascara . Accessed May 22, 2020.
  3. Srinivasan S, Otchere H, Yu M, Yang J, Luensmann D, Jones L. Impact of Cosmetics on the Surface Properties of Silicone Hydrogel Contact Lenses. Eye Contact Lens. 2015 July;41:228‐235.
  4. Luensmann D, Yu M, Yang J, Srinivasan S, Jones L. Impact of Cosmetics on the Physical Dimension and Optical Performance of Silicone Hydrogel Contact Lenses. Eye Contact Lens. 2015 Jul;41:218‐227.
  5. Luensmann D, van Doorn K, May C, Srinivasan S, Jones L. The Impact of Cosmetics on the Physical Dimension and Optical Performance of Contemporary Silicone Hydrogel Contact Lenses. Eye Contact Lens. 2020 May;46:166-173.

(p. 19) Myopia Matters – Dry Eye and Myopia Management
By Kate Gifford, PhD, BAppSc(Optom)Hons

  1. Greiner KL, Walline JJ. Dry eye in pediatric contact lens wearers. Eye Contact Lens. 2010 Nov;36:352-355.
  2. Han SB, Yang HK, Hyon JY, Hwang JM. Children with dry eye type conditions may report less severe symptoms than adult patients. Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251:791-796.
  3. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017 Jul;15:334-365.
  4. Jones LA, Walline JJ, Gaume A, et al. Purchase of contact lenses and contact-lenses-related symptoms following the Contact Lenses in Pediatrics (CLIP) Study. Cont Lens Anterior Eye. 2009 Aug;32:157-163.
  5. Wong J, Lan W, Ong LM, Tong L. Non-hormonal systemic medications and dry eye. Ocul Surf. 2011 Oct;9:212-226.
  6. Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II Introduction. The Ocular Surface.2017 Jul;15:269-275.
  7. Broide DH, Finkelman F, Bochner BS, Rothenberg ME. Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol. 2011 Mar;127:689-695.
  8. Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017 Jul;15:511-538.
  9. Wolffsohn JS, Emberlin JC. Role of contact lenses in relieving ocular allergy. Cont Lens Ant Eye. 2011 Aug;34:169-172.
  10. Rouse M, Borsting E, Mitchell GL, et al. Validity of the convergence insufficiency symptom survey: a confirmatory study. Optom Vis Sci. 2009 Apr;86:357-363.
  11. Rueff EM, King-Smith PE, Bailey MD. Can Binocular Vision Disorders Contribute to Contact Lens Discomfort? Optom Vis Sci. 2015 Sep;92:e214-e221.
  12. Gifford KL. Childhood and lifetime risk comparison of myopia control with contact lenses. Contact Lens Anterior Eye. 2020 Feb;43:26-32.

(p. 39) Scleral Lenses for Dry Eye and Ocular Surface Disease
By Kate A. McClure, OD, MS

  1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017 Jul;15:334-365.
  2. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276-283.
  3. Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017 Jul;15:438-510.
  4. Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001 Jun;76:593-599.
  5. Akpek EK, Klimava A, Thorne JE, Martin D, Lekhanont K, Ostrovsky A. Evaluation of patients with dry eye for presence of underlying Sjogren syndrome. Cornea. 2009 Jun;28:1073-1073.
  6. Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's syndrome international registry. Am J Ophthalmol. 2010 Mar;149:405-415.
  7. Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017 Jul;15:575-628.
  8. Bavinger JC, DeLoss K, Mian SI. Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol. 2015 Jul;26:319-324.
  9. Alipour F, Kheirkhah A, Behrouz MJ. Use of mini scleral contact lenses in moderate to severe dry eye. Cont Lens Anterior Eye. 2012 Dec;35:272-276.
  10. Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology. 2014 Jul;121:1398-1405.
  11. Lee SM, Kim YJ, Choi SH, Oh JY, Kim MK. Long-term effect of corneoscleral contact lenses on refractory ocular surface diseases. Cont Lens Anterior Eye. 2019 Aug;42:399-405.
  12. Rosenthal P, Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005 May;31:130-134.
  13. Dimit R, Gire A, Pflugfelder SC, Bergmanson JPG. Patient ocular conditions and clinical outcomes using a PROSE scleral device. Cont Lens Anterior Eye. 2013 Aug;36:159-163.
  14. Saboo US, Amparo F, Abud TB, Schaumberg DA, Dana R. Vision-related quality of life in patients with ocular graft-versus-host disease. Ophthalmology. 2015 Aug;122:1669-1674.
  15. Theophanous C, Irvine JA, Parker P, Chiu GB. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients With Ocular Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant. 2015 Dec;21:2180-2184.
  16. Jain R, Sharma N, Basu S, et al. Stevens-Johnson syndrome: The Role of an Ophthalmologist. Surv Ophthalmol. 2016 Jul-Aug;61:369-399.
  17. Papakostas TD, Le HG, Chodosh J, Jacobs DS. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis. Ophthalmology. 2015 Feb;122:248-253.
  18. Ciralsky JB, Chapman KO, Rosenblatt MI, et al. Treatment of Refractory Persistent Corneal Epithelial Defects: A Standardized Approach Using Continuous Wear PROSE Therapy. Ocul Immunol Inflamm. 2015 Jun;23:219-224.
  19. Schornack M, Nau C, Nau A, Harthan J, Fogt J, Shorter E. Visual and Physiological Outcomes of Scleral Lens Wear. Cont Lens Anterior Eye. 2019 Feb;42:3-8.
  20. Yin J, Jacobs DS. Long-term Outcome of Using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a Drug Delivery System for Bevacizumab in the Treatment of Corneal Neovascularization. Ocul Surf. 2019 Jan;17:134-141.
  21. Michaud L, van der Worp E, Brazeau D, Warde R, Giasson CJ. Predicting estimates of oxygen transmissibility for scleral lenses. Cont Lens Anterior Eye. 2012 Dec;35:266-271.
  22. van der Worp ED, Bornman D, Ferreira DL, Faria-Ribeiro M, Garcia-Porta N, Gonzalez-Meijome JM. Modern scleral contact lenses: A review. Cont Lens Anterior Eye. 2014 Aug;37:240-250.
  23. Vincent SJ, Alonso-Caneiro D, Collins MJ. The temporal dynamics of miniscleral contact lenses: Central corneal clearance and centration. Cont Lens Anterior Eye. 2018 Apr;41:162-168.
  24. Barnett M, Fadel D. Clinical Guide for Scleral Lens Success. 2018. Available at http://www.acculens.com/pdf/clinical-guide-success.pdf . Accessed June 24, 2020.

(p. 50) Scleral Lens Vault – When to use Scleral Lenses for Dry Eye Disease
By Langis Michaud, OD, MSc

  1. De Marchi SU, Cecchin E, De Marchi S. Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly. BMJ Case Rep. 2014 Sep 19;2014:bcr2014205146.
  2. Jones L, Downie LE, Korb D, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017 Jul;15:575-628.
  3. Wei Y, Asbell PA. The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 2014 Jul;40:248‐256. Erratum in Eye Contact Lens. 2014 Sep;40:311.
  4. Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017 Jul;15:539-574.

(p. 51) Orthokeratology Today – Orthokeratology: Not Cut-and-Dry
By Nicholas Despotidis, OD

  1. Lipson M. Dry Eye: Another Case for Orthokeratology. Contact Lens Spectrum. 2019 Jul;34:46.
  2. Wang X, Li J, Zhang R, et al. The Influence of Overnight Orthokeratology on Ocular Surface and Meibomian Gland Dysfunction in Teenagers with Myopia. J Opthalmol. 2019 Jan;2019;5142628.
  3. Weber AC, Burkat CN, Sundar G, Yen MT, Del Monte MA, Goel S. Entropion. 2020 Feb 8. Available at https://eyewiki.aao.org/Entropion . Accessed May 23, 2020.
  4. Tichenor AA, Ziemanski JF, Ngo W, Nichols JJ, Nichols KK. Tear Film and Meibomian Gland Characteristics in Adolescents. 2019 Dec;38:1475-1482.

(p. 52) Is This the New Norm? – Is “Crossing the Line” the New Normal?
By Mile Brujic, OD, & David L. Kading, OD

  1. Doughty MJ. Morphological Features of Cells Along Marx’s Line of the Marginal Conjunctiva of the Human Eyelid. Clin Exp Optom. 2013 Jan;96:76-84.
  2. Korb, Donald R, Blackie, Caroline A. Marx's Line of the Upper Lid is Visible in Upgaze Without Lid Eversion. Eye Contact Lens. 2010 May;36:149-151.
  3. Yamaguchi M, Kutsuna M, Uno T, Zheng X, Kodama T, Ohashi Y. Marx Line: Fluorescein Staining Line on the Inner Lid as Indicator of Meibomian Gland Function. Am J Ophthalmol. 2006 Apr;141:669-675.
  4. Korb DR, Blackie CA. Debridement-Scaling: A New Procedure That Increases Meibomian Gland Function and Reduces Dry Eye Symptoms. Cornea. 2013 Dec;32:1554-1557.
  5. Efron N, Brennan NA, Morgan PB, Wilson T. Lid wiper epitheliopathy. Prog Retin Eye Res. 2016 Jul;53:140-174.
  6. Korb DR, Greiner JV, Herman JP, et al. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J. 2002 Oct;28:211-216.
  7. Korb DR, Herman JP, Greiner JV, et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens. 2005 Jan;31:2-8.

(p. 56) Contact Lens Case Reports – The Dry Eye Battle with the Contact Lens Surface
By Gregory W. DeNaeyer, OD

  1. Pucker AD, Jones-Jordan LA, Marx S, et al. Clinical factors associated with contact lens dropout. Cont Lens Anterior Eye. 2019 Jun;42:318-324.
  2. Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007 Feb;26:168-174.